BioLife Solutions Gross Margin 2012-2026 | BLFS
Current and historical gross margin for BioLife Solutions (BLFS) over the last 10 years. The current gross profit margin for BioLife Solutions as of June 30, 2026 is %.
| BioLife Solutions Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $0.11B | $0.07B | 62.62% |
| 2026-03-31 | $0.10B | $0.06B | 62.75% |
| 2025-12-31 | $0.10B | $0.06B | 64.58% |
| 2025-09-30 | $0.09B | $0.06B | 67.05% |
| 2025-06-30 | $0.08B | $0.06B | 67.90% |
| 2025-03-31 | $0.08B | $0.05B | 67.95% |
| 2024-12-31 | $0.07B | $0.05B | 67.57% |
| 2024-09-30 | $0.04B | $0.04B | 116.22% |
| 2024-06-30 | $0.04B | $0.04B | 102.50% |
| 2024-03-31 | $0.05B | $0.04B | 79.59% |
| 2023-12-31 | $0.07B | $0.04B | 59.42% |
| 2023-09-30 | $0.05B | $0.04B | 88.00% |
| 2023-06-30 | $0.07B | $0.05B | 68.66% |
| 2023-03-31 | $0.08B | $0.05B | 62.03% |
| 2022-12-31 | $0.08B | $0.05B | 61.04% |
| 2022-09-30 | $0.16B | $0.05B | 29.68% |
| 2022-06-30 | $0.15B | $0.04B | 27.70% |
| 2022-03-31 | $0.14B | $0.04B | 28.99% |
| 2021-12-31 | $0.12B | $0.04B | 31.09% |
| 2021-09-30 | $0.10B | $0.04B | 40.21% |
| 2021-06-30 | $0.07B | $0.04B | 48.65% |
| 2021-03-31 | $0.05B | $0.03B | 52.83% |
| 2020-12-31 | $0.05B | $0.03B | 56.25% |
| 2020-09-30 | $0.04B | $0.02B | 58.54% |
| 2020-06-30 | $0.04B | $0.02B | 62.16% |
| 2020-03-31 | $0.03B | $0.02B | 67.65% |
| 2019-12-31 | $0.03B | $0.02B | 67.86% |
| 2019-09-30 | $0.03B | $0.02B | 72.00% |
| 2019-06-30 | $0.02B | $0.02B | 73.91% |
| 2019-03-31 | $0.02B | $0.02B | 76.19% |
| 2018-12-31 | $0.02B | $0.01B | 73.68% |
| 2018-09-30 | $0.02B | $0.01B | 70.59% |
| 2018-06-30 | $0.02B | $0.01B | 66.67% |
| 2018-03-31 | $0.01B | $0.01B | 61.54% |
| 2017-12-31 | $0.01B | $0.01B | 63.64% |
| 2017-09-30 | $0.01B | $0.01B | 60.00% |
| 2017-06-30 | $0.01B | $0.01B | 55.56% |
| 2017-03-31 | $0.01B | $0.00B | 50.00% |
| 2016-12-31 | $0.01B | $0.00B | 50.00% |
| 2016-09-30 | $0.01B | $0.00B | 50.00% |
| 2016-06-30 | $0.01B | $0.00B | 50.00% |
| 2016-03-31 | $0.01B | $0.00B | 57.14% |
| 2015-12-31 | $0.01B | $0.00B | 57.14% |
| 2015-09-30 | $0.01B | $0.00B | 57.14% |
| 2015-06-30 | $0.01B | $0.00B | 66.67% |
| 2015-03-31 | $0.01B | $0.00B | 66.67% |
| 2014-12-31 | $0.01B | $0.00B | 66.67% |
| 2014-09-30 | $0.01B | $0.00B | 66.67% |
| 2014-06-30 | $0.01B | $0.00B | 57.14% |
| 2014-03-31 | $0.01B | $0.00B | 50.00% |
| 2013-12-31 | $0.01B | $0.00B | 50.00% |
| 2013-09-30 | $0.01B | $0.00B | 50.00% |
| 2013-06-30 | $0.01B | $0.00B | 50.00% |
| 2013-03-31 | $0.01B | $0.00B | 42.86% |
| 2012-12-31 | $0.01B | $0.00B | 33.33% |
| 2012-09-30 | $0.01B | $0.00B | 20.00% |
| 2012-06-30 | $0.00B | 0 | 0.00% |
| 2012-03-31 | $0.00B | 0 | 0.00% |
| 2011-12-31 | $0.00B | 0 | 0.00% |
| 2011-09-30 | $0.00B | 0 | 0.00% |
| 2011-06-30 | $0.00B | 0 | 0.00% |
| 2011-03-31 | $0.00B | 0 | 0.00% |
| 2010-12-31 | $0.00B | 0 | 0.00% |
| 2010-09-30 | $0.00B | 0 | 0.00% |
| 2010-06-30 | $0.00B | 0 | 0.00% |
| 2010-03-31 | $0.00B | 0 | 0.00% |
| 2009-12-31 | $0.00B | 0 | 0.00% |
| 2009-09-30 | $0.00B | 0 | 0.00% |
| 2009-06-30 | $0.00B | 0 | 0.00% |
| 2009-03-31 | $0.00B | 0 | 0.00% |
| 2008-12-31 | $0.00B | 0 | 0.00% |
| 2008-09-30 | $0.00B | 0 | 0.00% |
| 2008-06-30 | $0.00B | 0 | 0.00% |
| 2008-03-31 | $0.00B | 0 | 0.00% |
| 2007-12-31 | $0.00B | 0 | 0.00% |
| 2007-09-30 | $0.00B | 0 | 0.00% |
| 2007-06-30 | $0.00B | 0 | 0.00% |
| 2007-03-31 | $0.00B | 0 | 0.00% |
| 2006-12-31 | $0.00B | 0 | 0.00% |
| 2006-09-30 | $0.00B | 0 | 0.00% |
| 2006-06-30 | $0.00B | 0 | 0.00% |
| 2006-03-31 | $0.00B | 0 | 0.00% |
| 2005-12-31 | $0.00B | 0 | 0.00% |
| 2005-09-30 | $0.00B | 0 | 0.00% |
| 2005-06-30 | $0.00B | 0 | 0.00% |
| 2005-03-31 | $0.00B | 0 | 0.00% |
| 2004-12-31 | $0.00B | 0 | 0.00% |
| 2004-09-30 | $0.00B | 0 | 0.00% |
| 2004-06-30 | $0.00B | 0 | 0.00% |
| 2004-03-31 | $0.00B | 0 | 0.00% |
| 2003-12-31 | $0.00B | 0 | 0.00% |
| 2003-09-30 | $0.00B | 0 | 0.00% |
| 2003-06-30 | $0.00B | 0 | 0.00% |
| 2003-03-31 | $0.00B | 0 | 0.00% |
| 2002-12-31 | $0.00B | 0 | 0.00% |
| 2002-09-30 | $0.00B | 0 | 0.00% |
| 2002-06-30 | $0.00B | 0 | 0.00% |
| 2002-03-31 | $0.00B | 0 | 0.00% |
| 2001-12-31 | $0.00B | 0 | 0.00% |
| 2001-09-30 | $0.00B | 0 | 0.00% |
| 2001-06-30 | $0.00B | 0 | 0.00% |
| 2001-03-31 | $0.00B | 0 | 0.00% |
| 2000-12-31 | $0.00B | 0 | 0.00% |
| 2000-09-30 | $0.00B | 0 | 0.00% |
| 2000-06-30 | $0.00B | 0 | 0.00% |
| 2000-03-31 | $0.00B | 0 | 0.00% |
| 1999-12-31 | $0.00B | 0 | 0.00% |
| 1999-09-30 | $0.00B | 0 | 0.00% |
| 1999-06-30 | $0.00B | 0 | 0.00% |
| 1999-03-31 | $0.00B | 0 | 0.00% |
| 1998-12-31 | $0.00B | 0 | 0.00% |
| 1998-09-30 | $0.00B | $0.00B | 25.00% |
| 1998-06-30 | $0.00B | $0.00B | 25.00% |
| 1998-03-31 | $0.00B | $0.00B | 25.00% |
| 1997-12-31 | $0.00B | $0.00B | 50.00% |
| 1997-09-30 | $0.00B | $0.00B | 25.00% |
| 1997-06-30 | $0.00B | $0.00B | 25.00% |
| 1997-03-31 | $0.00B | $0.00B | 25.00% |
| 1996-12-31 | $0.01B | $0.00B | 20.00% |
| 1996-09-30 | $0.01B | $0.00B | 33.33% |
| 1996-06-30 | $0.01B | $0.00B | 42.86% |
| 1996-03-31 | $0.01B | $0.01B | 55.56% |
| 1995-12-31 | $0.01B | $0.01B | 60.00% |
| 1995-09-30 | $0.01B | $0.01B | 53.85% |
| 1995-06-30 | $0.01B | $0.01B | 57.14% |
| 1995-03-31 | $0.02B | $0.01B | 53.33% |
| 1994-12-31 | $0.02B | $0.01B | 46.67% |
| 1994-09-30 | $0.01B | $0.01B | 50.00% |
| 1994-06-30 | $0.01B | $0.01B | 42.86% |
| 1994-03-31 | $0.01B | $0.01B | 38.46% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.733B | $0.096B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |